絞り込み

16555

広告

Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multicenter Study.

著者 Otowa-Suematsu N , Sakaguchi K , Nakamura T , Hara K , Kishi M , Hashimoto N , Yokota K , Yoshino H , Kuroki Y , Nishiumi T , Sou A , Komada H , Okada Y , Hirota Y , Tamori Y , Ogawa W
Diabetes Ther.2018 Sep 11 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (33view , 1users)

Full Text Sources

We comprehensively evaluated the effects of combination therapy with insulin glargine and the incretin-based drugs lixisenatide or vildagliptin in Japanese patients with type 2 diabetes.
PMID: 30206903 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード